↓ Skip to main content
What is this page? Embed badge

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome

Overview of attention for article published in European Heart Journal, August 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

policy
1 policy source
wikipedia
5 Wikipedia pages

Citations

dimensions_citation
155 Dimensions

Readers on

mendeley
110 Mendeley
Summary Policy documents Wikipedia Dimensions citations
So far, Dimensions has found 155 publications that cite this research output.

155

The most recent citing publications are shown below. View all 155 publications that cite this research output on Dimensions.

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.